{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:20:43Z","timestamp":1787026843881,"version":"build-2736575974"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.570100","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T09:38:04Z","timestamp":1601458684000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Initial Experience With the Next-Generation Resolute Onyx Zotarolimus-Eluting Stent in Symptomatic Intracranial Atherosclerotic Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Ameer E.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud H.","family":"Mohammaden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani Ramsey","family":"Rabah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wondwossen G.","family":"Tekle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/01.STR.26.1.14","article-title":"Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study","volume":"26","author":"Sacco","year":"1995","journal-title":"Stroke."},{"key":"B2","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1105335","article-title":"Stenting versus aggressive medical therapy for intracranial arterial stenosis","volume":"365","author":"Chimowitz","year":"2011","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jama.2015.1693","article-title":"Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial","volume":"313","author":"Zaidat","year":"2015","journal-title":"JAMA."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1161\/STROKEAHA.112.662270","article-title":"Randomized controlled trial of symptomatic middle cerebral artery stenosis","volume":"43","author":"Miao","year":"2012","journal-title":"Stroke."},{"key":"B5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1161\/STROKEAHA.118.023996","article-title":"WEAVE trial: final results in 152 on-label patients","volume":"50","author":"Alexander","year":"2019","journal-title":"Stroke."},{"key":"B6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12883-015-0443-9","article-title":"Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients","volume":"15","author":"Feng","year":"2015","journal-title":"BMC Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1161\/01.STR.0000190893.74268.fd","article-title":"Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up","volume":"36","author":"Abou-Chebl","year":"2005","journal-title":"Stroke."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1161\/01.STR.0000242481.38262.7b","article-title":"Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation","volume":"37","author":"Gupta","year":"2006","journal-title":"Stroke."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1227\/01.NEU.0000245593.54204.99","article-title":"Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis","volume":"59","author":"Qureshi","year":"2006","journal-title":"Neurosurgery."},{"key":"B10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1227\/01.NEU.0000335648.31874.37","article-title":"Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents: long-term follow-up at a single center","volume":"64","author":"Miao","year":"2009","journal-title":"Neurosurgery."},{"key":"B11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/159101991101700217","article-title":"Drug eluting stents for symptomatic intracranial and vertebral artery stenosis","volume":"17","author":"Fields","year":"2011","journal-title":"Interv Neuroradiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e340","DOI":"10.1161\/STROKEAHA.108.532713","article-title":"A systematic review on outcome after stenting for intracranial atherosclerosis","volume":"40","author":"Groschel","year":"2009","journal-title":"Stroke."},{"key":"B13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3174\/ajnr.A0869","article-title":"Influence of patient age and stenosis location on wingspan in-stent restenosis","volume":"29","author":"Turk","year":"2008","journal-title":"Am J Neuroradiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.112.097014","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials","volume":"125","author":"Bangalore","year":"2012","journal-title":"Circulation."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.jcin.2017.05.004","article-title":"First report of the resolute Onyx 2.0-mm zotarolimus-eluting stent for the treatment of coronary lesions with very small reference vessel diameter","volume":"10","author":"Price","year":"2017","journal-title":"JACC Cardiovasc Interv."},{"key":"B16","first-page":"643","article-title":"A standardized method for measuring intracranial arterial stenosis","volume":"21","author":"Samuels","year":"2000","journal-title":"Am J Neuroradiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/STROKEAHA.110.583245","article-title":"Balloon angioplasty for intracranial atherosclerotic disease: periprocedural risks and short-term outcomes in a multicenter study","volume":"42","author":"Nguyen","year":"2011","journal-title":"Stroke."},{"key":"B18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/neurintsurg-2018-014237","article-title":"Drug-coated balloons for the treatment of symptomatic intracranial atherosclerosis: initial experience and follow-up outcome","volume":"11","author":"Han","year":"2019","journal-title":"J Neurointerv Surg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1161\/01.STR.0000206142.03677.c2","article-title":"Angioplasty for symptomatic intracranial stenosis: clinical outcome","volume":"37","author":"Marks","year":"2006","journal-title":"Stroke."},{"key":"B20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/FJC.0b013e3180325b0a","article-title":"Zotarolimus, a novel sirolimus analogue with potent anti-proliferative activity on coronary smooth muscle cells and reduced potential for systemic immunosuppression","volume":"49","author":"Chen","year":"2007","journal-title":"J Cardiovasc Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00270-014-1001-3","article-title":"Solving the issue of restenosis after stenting of intracranial stenoses: experience with two thin-strut Drug-Eluting Stents (DES)-taxus element and resolute integrity","volume":"38","author":"Kurre","year":"2015","journal-title":"Cardiovasc Intervent Radiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/ATVBAHA.107.144220","article-title":"Vascular responses to drug eluting stents: importance of delayed healing","volume":"27","author":"Finn","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1227\/NEU.0b013e318286fdc8","article-title":"Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial","volume":"72","author":"Derdeyn","year":"2013","journal-title":"Neurosurgery."},{"key":"B24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jocn.2018.10.118","article-title":"Efficacy and safety of drug-eluting stent for the intracranial atherosclerotic disease: a systematic review and meta-analysis","volume":"59","author":"Ye","year":"2019","journal-title":"J Clin Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1161\/01.STR.0000128708.86762.d6","article-title":"Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results","volume":"35","year":"2004","journal-title":"Stroke."},{"key":"B26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ejvs.2010.05.007","article-title":"Predictive factors for in-stent restenosis after balloon-mounted stent placement for symptomatic intracranial atherosclerosis","volume":"40","author":"Zhu","year":"2010","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1161\/STROKEAHA.113.001824","article-title":"Higher risk of recurrent ischemic events in patients with intracranial in-stent restenosis","volume":"44","author":"Jin","year":"2013","journal-title":"Stroke."},{"key":"B28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1253\/circj.CJ-09-0059","article-title":"Molecular basis of restenosis and novel issues of drug-eluting stents","volume":"73","author":"Inoue","year":"2009","journal-title":"Circ J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/joic.12510","article-title":"Three-months optical coherence tomography analysis of a biodegradable polymer, sirolimus-eluting stent","volume":"31","author":"Kretov capital Ie","year":"2018","journal-title":"J Interv Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1109\/MPUL.2018.2870699","article-title":"Opening act: new multidisciplinary approaches yield thinner, stronger, better stents","volume":"9","author":"Mertz","year":"2018","journal-title":"IEEE Pulse."},{"key":"B31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ahj.2019.04.017","article-title":"Rationale and design of the Onyx ONE global randomized trial: a randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy","volume":"214","author":"Kedhi","year":"2019","journal-title":"Am Heart J."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.570100\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T09:38:06Z","timestamp":1601458686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.570100\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":31,"alternative-id":["10.3389\/fneur.2020.570100"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.570100","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]},"article-number":"570100"}}